| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 3.285 | 21.336 | 26.555 | 10.696 | 44.481 | 119.293 | 132.885 | 132.191 | 141.729 |
| Total Income - EUR | - | 3.285 | 21.337 | 26.555 | 10.747 | 45.260 | 118.659 | 134.873 | 132.202 | 141.735 |
| Total Expenses - EUR | - | 1.587 | 7.313 | 16.140 | 6.644 | 19.357 | 33.882 | 44.272 | 64.901 | 69.173 |
| Gross Profit/Loss - EUR | - | 1.698 | 14.023 | 10.416 | 4.103 | 25.903 | 84.777 | 90.601 | 67.301 | 72.562 |
| Net Profit/Loss - EUR | - | 1.600 | 13.433 | 9.619 | 3.781 | 25.352 | 83.608 | 89.299 | 66.006 | 68.395 |
| Employees | - | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 1 | 2 |
Check the financial reports for the company - Verdiamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 650 | 1.784 | 1.169 | 3.822 | 18.492 | 14.444 | 10.347 | 13.947 | 8.609 |
| Current Assets | - | 3.328 | 15.883 | 14.286 | 15.364 | 35.779 | 87.399 | 160.145 | 64.868 | 71.335 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 7.336 | 10.312 | 1.874 | 2.808 | 3.476 | 68.065 | 8.116 | 48.854 |
| Cash | - | 3.328 | 8.548 | 3.974 | 13.489 | 32.971 | 83.923 | 92.081 | 56.751 | 22.481 |
| Shareholders Funds | - | 1.644 | 13.482 | 9.676 | 13.269 | 32.603 | 83.657 | 89.347 | 66.054 | 68.443 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.334 | 4.185 | 5.828 | 6.168 | 20.603 | 18.627 | 81.835 | 13.940 | 12.128 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 1.334 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Verdiamed Srl